查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1813813

全球皮肤科 CRO 市场：市场规模、份额、趋势分析（按类型、服务和地区）、细分市场预测（2025-2033）

Dermatology CRO Market Size, Share & Trends Analysis Report By Type (Drug Discovery, Preclinical, Clinical), By Service (Clinical Monitoring, Project Management/Clinical Supply Management, Data Management), By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

皮肤科CRO市场概述

预计 2024 年全球皮肤病学 CRO 市场价值将达到 54.2 亿美元，到 2033 年将达到 90.9 亿美元，2025 年至 2033 年的复合年增长率为 5.80%。

皮肤病学委外研发机构(CRO) 市场正在经历强劲增长，主要原因是全球牛皮癣、湿疹、痤疮和皮肤癌等慢性皮肤病的盛行率不断上升。

此外，皮肤病学相关企业日益增长的兴趣、人们对皮肤病健康的认识不断提高以及创新局部和全身治疗的生物製药管道的不断扩大，进一步推动了对专业临床研究服务的需求。此外，皮肤病学研发投资的增加、个人化医疗的日益普及以及数位工具促进的患者参与度的提高等因素预计将支持市场成长。

此外，分散式临床试验、远距皮肤病学和人工智慧皮肤成像等新兴趋势正在重塑皮肤病学临床试验的格局，改善患者可近性和数据准确性。穿戴式皮肤感测器和先进成像技术的日益普及，进一步增强了即时监测和终点评估。整体而言，由于政府加强对皮肤病学研究的支持倡议，美容皮肤病学应用的拓展，以及亚太和拉丁美洲等新兴地区临床试验活动的增多，市场前景看好。

此外，CRO 正在采取策略性倡议，例如扩大其地理覆盖范围、与技术提供者合作以及投资整合数位平台，以提供全面的皮肤病学临床试验解决方案。此外，用于病变分析的人工智慧和机器学习、分散式临床试验平台和真实世界数据整合等技术进步使 CRO 能够提高临床试验效率、患者参与度和数据质量，从而增强其在这个充满活力的市场中的竞争地位。

目录

第一章 分析方法与范围

第二章执行摘要

第 3 章：皮肤科 CRO 市场：驱动因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 定价模式分析
  • 技术状况
  • 市场分析工具
    • 波特五力分析
    • PESTEL 与 SWOT 分析
    • COVID-19影响分析

第 4 章：皮肤科 CRO 市场：按类型估算和趋势分析

  • 皮肤科 CRO 市场：细分仪表板（按类型）
  • 皮肤科 CRO 市场：按类型进行趋势分析
  • 按类型（2021-2033）
  • 药物研发
    • 目标检验
    • 线索识别
    • 先导药物最适化
  • 临床前
  • 临床
    • 第一阶段
    • 第二阶段
    • 第三阶段
    • 第四阶段

第五章：皮肤科 CRO 市场：依服务估算与趋势分析

  • 皮肤科 CRO 市场：细分仪表板（按服务划分）
  • 皮肤科CRO市场：依服务类别的波动分析
  • 依服务分类（2021-2033 年）
  • 计划管理/临床供应管理
  • 资料管理
  • 监管/医疗事务
  • 医学写作
  • 临床监测
  • 品管/保证
  • 生物统计学
  • 研究人员付款
  • 实验室
  • 招募病患和设施
  • 科技
  • 其他的

第六章：皮肤科 CRO 市场：按地区分類的估计和趋势分析

  • 市场仪表板：按地区
  • 各地区市占率分析（2024 年及 2033 年）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 泰国
    • 韩国
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争态势

  • 市场参与企业分类
    • 市场领导
    • 新兴玩家
  • 公司市占率/评级分析（2024年）
  • 公司简介
    • IQVIA Inc.
    • Labcorp Drug Development
    • Thermo Fisher Scientific Inc.（PPD）
    • Parexel International Corp.
    • Charles River Laboratories
    • ICON, Plc
    • Syneos Health
    • Pharmaron
    • Aragen Life Sciences Ltd.
    • Wuxi AppTec
    • MEDPACE
    • CTI Clinical Trial &Consulting
    • Bioskin
    • Proinnovera GmbH
    • Biorasi, LLC
Product Code: GVR-4-68039-635-9

Dermatology CRO Market Summary

The global dermatology CRO market size was estimated at USD 5.42 billion in 2024 and is projected to reach USD 9.09 billion by 2033, growing at a CAGR of 5.80% from 2025 to 2033. The dermatology contract research organization (CRO) market is experiencing robust growth, primarily driven by the rising prevalence of chronic skin conditions such as psoriasis, eczema, acne, and skin cancers across the globe.

Besides, growing interest of dermatological companies and increasing awareness of dermatological health, coupled with the expansion of the biopharmaceutical pipeline for innovative topical and systemic therapies is further driving the demand for specialized clinical research services. In addition, factors such as growing investments in dermatology R&D, the rising adoption of personalized medicine, and enhanced patient participation facilitated by digital tools are expected to support the market growth.

Moreover, the emerging trends such as decentralized clinical trials, tele dermatology, and AI-powered skin imaging are reshaping the dermatology clinical trial landscape, improving patient access and data accuracy. The increased use of wearable skin sensors and advanced imaging technologies is further enhancing real-time monitoring and endpoint assessment. Overall, the market scenario is favorable due to rising government initiatives supporting dermatology research, expanding applications in cosmetic dermatology, and increased clinical trial activity in emerging regions like Asia-Pacific and Latin America.

Furthermore, the CROs are taking strategic initiatives such as expanding their geographic presence, forming partnerships with technology providers, and investing in integrated digital platforms to offer comprehensive dermatology trial solutions. In addition, technology advancements, including AI and machine learning for lesion analysis, decentralized trial platforms, and the integration of real-world data, enable CROs to enhance trial efficiency, patient engagement, and data quality, strengthening their competitive position in this dynamic market.

Global Dermatology CRO Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global dermatology CRO market report based on type, service, and region.

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Drug Discovery
    • Target Validation
    • Lead Identification
    • Lead optimization
  • Preclinical
  • Clinical
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
  • Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Project Management/Clinical Supply Management
  • Data Management
  • Regulatory/Medical Affairs
  • Medical Writing
  • Clinical Monitoring
  • Quality Management/ Assurance
  • Bio-statistics
  • Investigator Payments
  • Laboratory
  • Patient and Site Recruitment
  • Technology
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Thailand
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Argentina
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Service
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Value-Chain-Based Sizing & Forecasting
    • 1.7.3. Multivariate Model Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Dermatology CRO Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising Prevalence of Chronic and Complex Skin Disorders
      • 3.2.1.2. Increasing Adoption of Advanced Technologies
      • 3.2.1.3. Growing Demand for Aesthetic Dermatology and Cosmeceuticals
      • 3.2.1.4. Increasing Outsourcing of R&D Activities
      • 3.2.1.5. Favorable Environment for Clinical Trials in Developing Countries
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Quality Issues of CRO Services
      • 3.2.2.2. Intellectual Property Rights Issues
  • 3.3. Pricing Model Analysis
  • 3.4. Technology Landscape
  • 3.5. Market Analysis Tools
    • 3.5.1. Porter's Five Force Analysis
    • 3.5.2. PESTEL by SWOT Analysis
    • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Dermatology CRO Market: Type Estimates & Trend Analysis

  • 4.1. Dermatology CRO Market, By Type: Segment Dashboard
  • 4.2. Dermatology CRO Market, By Type: Movement Analysis
  • 4.3. Dermatology CRO Market Estimates & Forecasts, By Type, 2021 - 2033 (USD Million)
  • 4.4. Drug Discovery
    • 4.4.1. Drug Discovery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Target Validation
      • 4.4.2.1. Target Validation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Lead Identification
      • 4.4.3.1. Lead Identification Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. Lead Optimization
      • 4.4.4.1. Lead Optimization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Preclinical
    • 4.5.1. Preclinical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Clinical
    • 4.6.1. Clinical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.2. Phase I
      • 4.6.2.1. Phase I Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.3. Phase II
      • 4.6.3.1. Phase II Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.4. Phase III
      • 4.6.4.1. Phase III Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.5. Phase IV
      • 4.6.5.1. Phase IV Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Dermatology CRO Market: Service Estimates & Trend Analysis

  • 5.1. Dermatology CRO Market, By Service: Segment Dashboard
  • 5.2. Dermatology CRO Market, By Service: Movement Analysis
  • 5.3. Dermatology CRO Market Estimates & Forecasts, By Service, 2021 - 2033 (USD Million)
  • 5.4. Project Management/Clinical Supply Management
    • 5.4.1. Project Management/Clinical Supply Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Data Management
    • 5.5.1. Data Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Regulatory/Medical Affairs
    • 5.6.1. Regulatory/Medical Affairs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Medical Writing
    • 5.7.1. Medical Writing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Clinical Monitoring
    • 5.8.1. Clinical Monitoring Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Quality Management/ Assurance
    • 5.9.1. Quality Management/ Assurance Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.10. Bio-statistics
    • 5.10.1. Bio-statistics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.11. Investigator Payments
    • 5.11.1. Investigator Payments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.12. Laboratory
    • 5.12.1. Laboratory Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.13. Patient and Site Recruitment
    • 5.13.1. Patient and Site Recruitment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.14. Technology
    • 5.14.1. Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.15. Others
    • 5.15.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Dermatology CRO Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Dashboard
  • 6.2. Regional Market Share Analysis, 2024 & 2033
  • 6.3. North America
    • 6.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.2. U.S
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Competitive Scenario
      • 6.3.2.3. Regulatory Framework
      • 6.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. Regulatory Framework
      • 6.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.4. Mexico
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Competitive Scenario
      • 6.3.4.3. Regulatory Framework
      • 6.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Europe
    • 6.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.2. UK
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Competitive Scenario
      • 6.4.5.3. Regulatory Framework
      • 6.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Competitive Scenario
      • 6.4.6.3. Regulatory Framework
      • 6.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.7. Denmark
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Competitive Scenario
      • 6.4.7.3. Regulatory Framework
      • 6.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.8. Sweden
      • 6.4.8.1. Key Country Dynamics
      • 6.4.8.2. Competitive Scenario
      • 6.4.8.3. Regulatory Framework
      • 6.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.9. Norway
      • 6.4.9.1. Key Country Dynamics
      • 6.4.9.2. Competitive Scenario
      • 6.4.9.3. Regulatory Framework
      • 6.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. Japan
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. China
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Competitive Scenario
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Competitive Scenario
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.7. Australia
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Competitive Scenario
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. MEA
    • 6.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.3. Saudi Arabia
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Competitive Scenario
      • 6.7.4.3. Regulatory Framework
      • 6.7.4.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Competitive Scenario
      • 6.7.5.3. Regulatory Framework
      • 6.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
    • 7.1.1. Market Leaders
    • 7.1.2. Emerging Players
  • 7.2. Company Market Share/Assessment Analysis, 2024
  • 7.3. Company Profiles
    • 7.3.1. IQVIA Inc.
      • 7.3.1.1. Company Overview
      • 7.3.1.2. Financial Performance
      • 7.3.1.3. Service Benchmarking
      • 7.3.1.4. Strategic Initiatives
    • 7.3.2. Labcorp Drug Development
      • 7.3.2.1. Company Overview
      • 7.3.2.2. Financial Performance
      • 7.3.2.3. Service Benchmarking
      • 7.3.2.4. Strategic Initiatives
    • 7.3.3. Thermo Fisher Scientific Inc. (PPD)
      • 7.3.3.1. Company Overview
      • 7.3.3.2. Financial Performance
      • 7.3.3.3. Service Benchmarking
      • 7.3.3.4. Strategic Initiatives
    • 7.3.4. Parexel International Corp.
      • 7.3.4.1. Company Overview
      • 7.3.4.2. Financial Performance
      • 7.3.4.3. Service Benchmarking
      • 7.3.4.4. Strategic Initiatives
    • 7.3.5. Charles River Laboratories
      • 7.3.5.1. Company Overview
      • 7.3.5.2. Financial Performance
      • 7.3.5.3. Service Benchmarking
      • 7.3.5.4. Strategic Initiatives
    • 7.3.6. ICON, Plc
      • 7.3.6.1. Company Overview
      • 7.3.6.2. Financial Performance
      • 7.3.6.3. Service Benchmarking
      • 7.3.6.4. Strategic Initiatives
    • 7.3.7. Syneos Health
      • 7.3.7.1. Company Overview
      • 7.3.7.2. Financial Performance
      • 7.3.7.3. Service Benchmarking
      • 7.3.7.4. Strategic Initiatives
    • 7.3.8. Pharmaron
      • 7.3.8.1. Company Overview
      • 7.3.8.2. Financial Performance
      • 7.3.8.3. Service Benchmarking
      • 7.3.8.4. Strategic Initiatives
    • 7.3.9. Aragen Life Sciences Ltd.
      • 7.3.9.1. Company Overview
      • 7.3.9.2. Financial Performance
      • 7.3.9.3. Service Benchmarking
      • 7.3.9.4. Strategic Initiatives
    • 7.3.10. Wuxi AppTec
      • 7.3.10.1. Company Overview
      • 7.3.10.2. Financial Performance
      • 7.3.10.3. Service Benchmarking
      • 7.3.10.4. Strategic Initiatives
    • 7.3.11. MEDPACE
      • 7.3.11.1. Company Overview
      • 7.3.11.2. Financial Performance
      • 7.3.11.3. Service Benchmarking
      • 7.3.11.4. Strategic Initiatives
    • 7.3.12. CTI Clinical Trial & Consulting
      • 7.3.12.1. Company Overview
      • 7.3.12.2. Financial Performance
      • 7.3.12.3. Service Benchmarking
      • 7.3.12.4. Strategic Initiatives
    • 7.3.13. Bioskin
      • 7.3.13.1. Company Overview
      • 7.3.13.2. Financial Performance
      • 7.3.13.3. Service Benchmarking
      • 7.3.13.4. Strategic Initiatives
    • 7.3.14. Proinnovera GmbH
      • 7.3.14.1. Company Overview
      • 7.3.14.2. Financial Performance
      • 7.3.14.3. Service Benchmarking
      • 7.3.14.4. Strategic Initiatives
    • 7.3.15. Biorasi, LLC
      • 7.3.15.1. Company Overview
      • 7.3.15.2. Financial Performance
      • 7.3.15.3. Service Benchmarking
      • 7.3.15.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 4 Global Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 5 Global Dermatology CRO Market Estimates and Forecasts, by Region, 2021 - 2033 (USD Million)
  • Table 6 North America Dermatology CRO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 7 North America Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 8 North America Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 9 U.S. Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 10 U.S. Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 11 Canada Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 12 Canada Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 13 Mexico Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 14 Mexico Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 15 Europe Dermatology CRO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 16 Europe Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 17 Europe Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 18 UK Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 19 UK Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 20 Germany Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 21 Germany Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 22 France Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 23 France Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 24 Italy Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 25 Italy Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 26 Spain Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 27 Spain Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 28 Denmark Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 29 Denmark Dermatology CRO Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 30 Sweden Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 31 Sweden Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 32 Norway Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 33 Norway Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 34 Asia Pacific Dermatology CRO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 35 Asia Pacific Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 36 Asia Pacific Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 37 Japan Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 38 Japan Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 39 China Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 40 China Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 41 India Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 42 India Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 43 Thailand Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 44 Thailand Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 45 South Korea Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 46 South Korea Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 47 Australia Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 48 Australia Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 49 Latin America Dermatology CRO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 50 Latin America Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 51 Latin America Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 52 Brazil Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 53 Brazil Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 54 Argentina Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 55 Argentina Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 56 Middle East & Africa Dermatology CRO Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 57 Middle East & Africa Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 58 Middle East & Africa Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 59 South Africa Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 60 South Africa Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 61 Saudi Arabia Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 62 Saudi Arabia Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 63 UAE Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 64 UAE Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 65 Kuwait Dermatology CRO Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
  • Table 66 Kuwait Dermatology CRO Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Commodity Flow Analysis
  • Fig. 7 Value-chain Based Sizing & Forecasting
  • Fig. 8 QFD Model Sizing & Forecasting
  • Fig. 9 Bottom-up Approach
  • Fig. 10 Market Snapshot
  • Fig. 11 Segment Snapshot 1
  • Fig. 12 Segment Snapshot 2
  • Fig. 13 Competitive Landscape Snapshot
  • Fig. 14 Parent Market Outlook, 2024 (USD Billion)
  • Fig. 15 Ancillary Market Outlook, 2024 (USD Billion)
  • Fig. 16 Dermatology CRO Market Dynamics
  • Fig. 17 Porter's Five Forces Analysis
  • Fig. 18 PESTEL Analysis
  • Fig. 19 Dermatology CRO Market: Type Outlook and Key Takeaways
  • Fig. 20 Dermatology CRO Market: Type Movement Analysis
  • Fig. 21 Drug Discovery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Target Validation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Lead Identification Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Lead optimization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Preclinical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Clinical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Phase I Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Phase II Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Phase III Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Phase IV Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Dermatology CRO Market: Service Outlook and Key Takeaways
  • Fig. 32 Dermatology CRO Market: Service Movement Analysis
  • Fig. 33 Project Management/Clinical Supply Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Data Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Regulatory/Medical Affairs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Medical Writing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Clinical Monitoring Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Quality Management/ Assurance Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Bio-statistics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Investigator Payments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Laboratory Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Patient and Site Recruitment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Regional Marketplace: Key Takeaways
  • Fig. 46 North America Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 U.S. Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Canada Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Mexico Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Europe Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 UK Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Germany Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 France Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Italy Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Spain Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Denmark Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Sweden Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Norway Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Asia Pacific Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Japan Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 China Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 India Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 Thailand Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 South Korea Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Australia Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Latin America Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Brazil Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 Argentina Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 88 MEA Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 South Africa Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 Saudi Arabia Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 UAE Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 Kuwait Dermatology CRO Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 97 Key Company Categorization
  • Fig. 98 Service Heat Map Analysis
  • Fig. 99 Strategic Framework